ArticleFrontiers in bioengineering and biotechnology2026
The outcome of digital technology in microvascular free flap reconstruction for ORNJ: a retrospective study.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Osteoradionecrosis of the jaw (ORNJ) is a serious and refractory late complication of radiotherapy used in the treatment of head and neck cancer. Microvascular free flap reconstruction is an ideal option to reconstruct the residual defect after surgical resection of ORNJ lesion. The application of virtual surgical planning (VSP) and three-dimensional printing (3DP) can effectively improve the reconstructive results with free flaps in jaw bone defect. However, the effect of VSP and 3DP in ORNJ reconstruction with free flaps is still unclear. A retrospective study was conducted to evaluate the free flap types, the success rate, and complications in ORNJ. Methods: The ORNJ inpatients that underwent free flaps reconstruction in our hospital between 2012 and 2024 were included in the study and divided into the conventional flap (CF) and digital flap (DF) groups with the application of VSP and 3DP. The patient characteristics and microvascular free flap reconstruction outcome were reviewed. Results: A total of 35 ORNJ patients with 39 free flaps were included in the study. The success rate of free flaps reconstruction in ORNJ was 89.7%, with the postoperative early complication rate of 58.9% and late complication rate of 25.6%. Fibula was the most commonly used flap type (76.9%) of ORNJ defect reconstruction and had the lowest complication rate (63.3%). The success rate between the CF (92.9%) and DF (88%) groups had no significant difference. The mean surgical duration and the length of hospital stay in the DF group were significantly shorter than those of the CF group. Moreover, the difference of the postoperative complication rate between the CF (78.6%) and DF (64%) groups was not statistically significant. The fistula formation rate was significantly lower in the DF group than in the CF group. Conclusion: Microvascular free flap reconstruction is safe and effective for advanced osteoradionecrosis of the jaw, with the fibula flap representing the most favorable donor site. The adjunctive use of virtual surgical planning and three-dimensional printing significantly reduces the operative time, length of hospital stay, and fistula formation. These digital techniques are valuable adjuvant tools that optimize surgical efficiency and decrease critical complications in ORNJ reconstruction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.